data_1btq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1btq _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.657 . . . . . . . . 2.1 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.27 -37.95 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.686 . . . . 2.28 109.421 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -38.43 89.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.702 . . . . 2.52 109.479 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.77 71.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.503 -0.748 . . . . 1.47 110.067 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.36 64.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.619 -0.676 . . . . 1.34 110.542 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.9 t -54.09 -37.88 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.61 -0.681 . . . . 1.39 110.683 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 7' ' ' ILE . 50.9 mm -70.11 -33.13 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.382 -0.824 . . . . 2.18 109.543 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.95 -38.4 88.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.506 -0.746 . . . . 3.09 109.454 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 9' ' ' ILE . 58.4 mt -75.19 -29.64 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.573 -0.704 . . . . 1.93 109.473 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.54 -40.79 97.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 2.84 109.182 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.4 -34.67 68.04 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.092 -0.707 . . . . 2.76 109.092 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.53 84.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 1.2 109.795 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.71 -36.3 62.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.56 -0.712 . . . . 1.5 109.321 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 mt -83.75 -1.84 55.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.606 -0.683 . . . . 2.91 110.847 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -55.25 45.14 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.026 -1.046 . . . . 2.14 110.058 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.1 -26.39 9.28 Favored 'Trans proline' 0 N--CA 1.501 1.913 1 C-N-CA 125.854 4.37 . . . . 1.61 110.008 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.68 -26.78 63.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.522 -0.736 . . . . 1.39 109.694 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.5 mt -99.53 -21.44 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.395 -0.815 . . . . 3.5 110.088 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.5 m -58.68 152.55 18.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.237 -0.915 . . . . 2.73 109.839 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -98.97 33.33 2.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.602 -0.686 . . . . 6.9 109.316 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.13 -43.79 1.36 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.49 -1.444 . . . . 6.03 109.49 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.331 0 O-C-N 119.829 -1.983 . . . . 6.8 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.657 . . . . . . . . 1.53 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.27 -37.95 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.686 . . . . 1.71 109.421 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -38.43 89.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.702 . . . . 2.0099999999999998 109.479 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.77 71.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.503 -0.748 . . . . 0.89000000000000001 110.067 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.36 64.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.619 -0.676 . . . . 0.70999999999999996 110.542 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.9 t -54.09 -37.88 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.61 -0.681 . . . . 0.77000000000000002 110.683 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.9 mm -70.11 -33.13 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.382 -0.824 . . . . 1.5900000000000001 109.543 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.95 -38.4 88.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.506 -0.746 . . . . 2.2400000000000002 109.454 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.4 mt -75.19 -29.64 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.573 -0.704 . . . . 1.28 109.473 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.54 -40.79 97.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 2.23 109.182 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.4 -34.67 68.04 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.092 -0.707 . . . . 2.0099999999999998 109.092 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.53 84.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.71999999999999997 109.795 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.71 -36.3 62.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.56 -0.712 . . . . 0.98999999999999999 109.321 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 mt -83.75 -1.84 55.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.606 -0.683 . . . . 2.3700000000000001 110.847 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -55.25 45.14 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.026 -1.046 . . . . 1.8 110.058 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.1 -26.39 9.28 Favored 'Trans proline' 0 N--CA 1.501 1.913 1 C-N-CA 125.854 4.37 . . . . 1.3300000000000001 110.008 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.68 -26.78 63.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.522 -0.736 . . . . 1.29 109.694 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.5 mt -99.53 -21.44 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.395 -0.815 . . . . 2.9199999999999999 110.088 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.5 m -58.68 152.55 18.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.237 -0.915 . . . . 2.73 109.839 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -98.97 33.33 2.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.602 -0.686 . . . . 6.0800000000000001 109.316 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.13 -43.79 1.36 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.49 -1.444 . . . . 6.0300000000000002 109.49 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.331 0 O-C-N 119.829 -1.983 . . . . 6.1799999999999997 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.657 . . . . . . . . 1.53 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.27 -37.95 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.686 . . . . 1.71 109.421 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -38.43 89.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.702 . . . . 2.01 109.479 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.77 71.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.503 -0.748 . . . . 0.89 110.067 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.36 64.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.619 -0.676 . . . . 0.71 110.542 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.9 t -54.09 -37.88 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.61 -0.681 . . . . 0.77 110.683 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.9 mm -70.11 -33.13 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.382 -0.824 . . . . 1.59 109.543 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.95 -38.4 88.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.506 -0.746 . . . . 2.24 109.454 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.4 mt -75.19 -29.64 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.573 -0.704 . . . . 1.28 109.473 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.54 -40.79 97.93 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 2.23 109.182 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.4 -34.67 68.04 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.092 -0.707 . . . . 2.01 109.092 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.53 84.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.72 109.795 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.71 -36.3 62.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.56 -0.712 . . . . 0.99 109.321 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 mt -83.75 -1.84 55.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.606 -0.683 . . . . 2.37 110.847 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -55.25 45.14 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.026 -1.046 . . . . 1.8 110.058 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.1 -26.39 9.28 Favored 'Trans proline' 0 N--CA 1.501 1.913 1 C-N-CA 125.854 4.37 . . . . 1.33 110.008 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.68 -26.78 63.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.522 -0.736 . . . . 1.29 109.694 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.5 mt -99.53 -21.44 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.395 -0.815 . . . . 2.92 110.088 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.5 m -58.68 152.55 18.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.237 -0.915 . . . . 2.73 109.839 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -98.97 33.33 2.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.602 -0.686 . . . . 6.08 109.316 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.13 -43.79 1.36 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.49 -1.444 . . . . 6.03 109.49 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.331 0 O-C-N 119.829 -1.983 . . . . 6.18 . . . . . . . . . . 0 0 . 1 stop_ save_